| scholarly article | Q13442814 |
| P50 | author | Claudio Da Cunha | Q42869588 |
| P2093 | author name string | R N Takahashi | |
| M T Tadaiesky | |||
| P A Dombrowski | |||
| P2860 | cites work | Short-term memory is modulated by the spontaneous release of endocannabinoids: evidence from hippocampal population codes. | Q51972182 |
| Premotor Parkinson disease | Q64861028 | ||
| Early diagnosis of Parkinson's disease | Q78775343 | ||
| Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys | Q80609691 | ||
| Cannabinoids, hippocampal function and memory | Q28142949 | ||
| The molecular logic of endocannabinoid signalling | Q29615356 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions | Q35045001 | ||
| CB1 cannabinoid receptor signalling in Parkinson's disease | Q35054346 | ||
| Role of endogenous cannabinoids in cognition and emotionality | Q36198923 | ||
| Distribution of cannabinoid receptors in the central and peripheral nervous system. | Q36441196 | ||
| The endocannabinoid system and extinction learning | Q36977769 | ||
| Endocannabinoid signals in the control of emotion | Q37373954 | ||
| Behavioural despair in rats: A new model sensitive to antidepressant treatments | Q40134604 | ||
| Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease | Q40358139 | ||
| Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice | Q42615187 | ||
| Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. | Q43164962 | ||
| Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease | Q43504648 | ||
| Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | Q44102387 | ||
| Ethanol improves short-term social memory in rats. Involvement of opioid and muscarinic receptors | Q44318880 | ||
| Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder | Q44915184 | ||
| Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents | Q45251047 | ||
| Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism | Q45310537 | ||
| Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. | Q46346508 | ||
| High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. | Q46456086 | ||
| A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease | Q46491157 | ||
| Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. | Q48545197 | ||
| Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. | Q48973251 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 238491 | |
| P577 | publication date | 2010-09-26 | |
| P1433 | published in | Parkinson's disease | Q27723341 |
| P1476 | title | Effects of SR141716A on Cognitive and Depression-Related Behavior in an Animal Model of Premotor Parkinson's Disease | |
| P478 | volume | 2010 |
| Q37398726 | Behavioral effects of bidirectional modulators of brain monoamines reserpine and d-amphetamine in zebrafish |
| Q39368845 | Endocannabinoid system in neurodegenerative disorders. |
| Q35158376 | Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? |
| Q35713057 | Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial |
| Q64086843 | Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease |
Search more.